The EMBO Journal (2003) 22, 6267–6276, doi:10.1093/emboj/cdg599
|
| Supplementary information |
| Osteocyte control of bone formation via sclerostin, a novel BMP antagonist |
| David G. Winkler, May Kung Sutherland, James C. Geoghegan, Changpu Yu, Trenton Hayes, John E. Skonier, Diana Shpektor, Mechtild Jonas, Brian R. Kovacevich, Karen Staehling-Hampton, Mark Appleby, Mary E. Brunkow and John A. Latham |
|